Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Gamalat A Elgedawy"'
Autor:
Gamalat A Elgedawy, Mohamed Samir, Naglaa S Elabd, Hala H Elsaid, Mohamed Enar, Radwa H Salem, Belal A Montaser, Hind S AboShabaan, Randa M Seddik, Shimaa M El-Askaeri, Marwa M Omar, Marwa L Helal
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0302977 (2024)
BackgroundAfter its emergence in China, the coronavirus SARS-CoV-2 has swept the world, leading to global health crises with millions of deaths. COVID-19 clinical manifestations differ in severity, ranging from mild symptoms to severe disease. Althou
Externí odkaz:
https://doaj.org/article/ff3875041d114bae9c003eb1048e0f96
Autor:
Asmaa M. Elbrolosy, Naglaa S. Elabd, Gamalat A. ElGedawy, Mai Abozeid, Mervat Abdelkreem, Belal Montaser, Emad M. Eed, Moamena S. Elhamouly
Publikováno v:
Clinical and Experimental Medicine.
Chronic hepatitis B (CHB) has a wide range of outcomes depending on host immune responses mainly Toll-like receptors (TLRs) signaling and released cytokines. Toll-like receptor 2 (TLR2) single nucleotide polymorphisms (SNPs) and interleukin 6 (IL-6)
Autor:
Gamalat A Elgedawy, Warda Othman, Maha M. Elsabaawy, Marwa Helal, Nashwa Shebl, Eman Abdelsameea, Dalia M Elsabaawy, Fathia I El-Bassal, Samar Ghanem
Publikováno v:
Expert review of anti-infective therapy. 18(9)
Background: Despite the outstanding results of direct-acting antiviral therapies (DAAs) of Hepatitis C infection (HCV), non-responders had to be more defined. Aim: assess the outcome of DAAs in lin...